FDA Adverse Event Injury Summary report: N

TOTAL ASR FEM IMP SIZE 46

MDR report key: 7305750 · Received March 1, 2018

Report

Report Number
1818910-2018-54324
Event Type
Injury
Date Received
March 1, 2018
Date of Event
November 28, 2013
Report Date
January 31, 2018
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. PRODUCT COMPLAINT # ==> PC-(B)(4) INVESTIGATION SUMMARY ==> THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN. THE INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS WAS CONDUCTED UNDER MDD CAPA-(B)(4). ONGOING POST MARKET SURVEILLANCE IS CONDUCTED PER OUR PROCEDURES FOR THIS PRODUCT.

Description of Event or Problem · 1

INITIAL PROCEDURE, (B)(6) 2006 : RIGHT TOTAL HIP ARTHROPLASTY OF THE RESURFACING TYPE IT WAS REPORTED BY LEGAL THAT THE PATIENT WAS REVISED ON (B)(6) 2013 DUE TO SUSPECTED METALLIC EROSION ON RIGHT HIP RESURFACING PROSTHESIS. PATIENT WAS ORIGINALLY IMPLANTED WITH SIZE 46 ASR FEMORAL COMPONENT AND SIZE 52 ASR ACETABULAR COMPONENT. POSTOP DIAGNOSIS INDICATED THAT THERE WAS A RIGHT HIP PSEUDOTUMOR AND METALLOSIS. REVISED WITH NON -DEPUY SYNTHES PRODUCT. DEVICES INVOLVED: 9998-04-652 TOTAL ACETABULAR IMPLANT SIZE 52, LOT 1870304. THE 9998-03-946 FEMORAL IMPLANT SIZE 46, LOT 2021704.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
149216 TOTAL ASR FEM IMP SIZE 46 ASR HIP SYSTEM : HIP METAL FEMORAL HEADS KWA DEPUY INTERNATIONAL LTD. 8010379 2021704

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention